Cargando…

In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial

BACKGROUND: Loss of mitochondrial function contributes to fatigue, exercise intolerance and muscle weakness, and is a key factor in the disability that develops with age and a wide variety of chronic disorders. Here, we describe the impact of a first-in-class cardiolipin-binding compound that is tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roshanravan, Baback, Liu, Sophia Z., Ali, Amir S., Shankland, Eric G., Goss, Chessa, Amory, John K., Robertson, H. Thomas, Marcinek, David J., Conley, Kevin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282018/ https://www.ncbi.nlm.nih.gov/pubmed/34264994 http://dx.doi.org/10.1371/journal.pone.0253849

Ejemplares similares

Building strength, endurance, and mobility using an astaxanthin formulation with functional training in elderly
por: Liu, Sophia Z., et al.
Publicado: (2018)

Astaxanthin supplementation enhances metabolic adaptation with aerobic training in the elderly
por: Liu, Sophia Z., et al.
Publicado: (2021)

Elamipretide effects on the skeletal muscle phosphoproteome in aged female mice
por: Campbell, Matthew D., et al.
Publicado: (2022)

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2018)

Elamipretide Improves Mitochondrial Function in the Failing Human Heart
por: Chatfield, Kathryn C., et al.
Publicado: (2019)

Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure
por: Sabbah, Hani N., et al.
Publicado: (2019)

A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2020)

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration
por: Nhu, Nguyen Thanh, et al.
Publicado: (2022)

ATP and NAD(+) Deficiency in Parkinson’s Disease
por: Mischley, Laurie K., et al.
Publicado: (2023)

Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
por: Sabbah, Hani N.
Publicado: (2020)

Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide
por: Sabbah, Hani N., et al.
Publicado: (2018)

Effects of Elamipretide on Autophagy in Renal Cells of Pigs with Metabolic Syndrome
por: Hong, Siting, et al.
Publicado: (2022)

The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT)
por: Pharaoh, Gavin, et al.
Publicado: (2023)

Dissecting the Obesity Paradox in Patients With Obesity and CKD
por: Alzayer, Husam, et al.
Publicado: (2023)

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
por: Zhao, Weixing, et al.
Publicado: (2019)

Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial
por: Karaa, Amel, et al.
Publicado: (2023)

Elamipretide Improves ADP Sensitivity in Aged Mitochondria by Increasing Uptake through the Adenine Nucleotide Translocator (ANT)
por: Pharaoh, Gavin, et al.
Publicado: (2023)

Mitochondrial NAD(P)H In vivo: Identifying Natural Indicators of Oxidative Phosphorylation in the (31)P Magnetic Resonance Spectrum
por: Conley, Kevin E., et al.
Publicado: (2016)

The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis
por: Grosser, Joshua A., et al.
Publicado: (2021)

Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice
por: Zuo, Youmei, et al.
Publicado: (2020)

Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial
por: Liu, Sophia, et al.
Publicado: (2022)

Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats
por: Wu, Jing, et al.
Publicado: (2017)

Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid
por: Sabbah, Hani N.
Publicado: (2021)

Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome
por: Hornby, Brittany, et al.
Publicado: (2022)

Elamipretide mitigates ischemia-reperfusion injury in a swine model of hemorrhagic shock
por: Patel, N., et al.
Publicado: (2023)

Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data
por: Van den Eynde, Jef, et al.
Publicado: (2023)

Elamipretide reduces pyroptosis and improves functional recovery after spinal cord injury
por: Jiang, Wu, et al.
Publicado: (2023)

Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease
por: Gamboa, Jorge L., et al.
Publicado: (2016)

The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats
por: Allen, Mitchell E., et al.
Publicado: (2020)

Longitudinal Association between Serum Leptin Concentration and Glomerular Filtration Rate in Humans
por: Pedone, Claudio, et al.
Publicado: (2015)

Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2-induced lysosomal membrane permeabilization
por: Zhang, Haojie, et al.
Publicado: (2023)

Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases
por: Koenig, Mary Kay, et al.
Publicado: (2022)

SEX DIFFERENCES IN SKELETAL MUSCLE ENERGETICS AMONG OLDER ADULTS
por: Kramer, Philip, et al.
Publicado: (2022)

Coenzyme Q(10) dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
por: Yeung, Catherine K., et al.
Publicado: (2015)

A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism
por: Reid Thompson, W., et al.
Publicado: (2020)

The Measurement of Reversible Redox Dependent Post-translational Modifications and Their Regulation of Mitochondrial and Skeletal Muscle Function
por: Kramer, Philip A., et al.
Publicado: (2015)

ATP metabolism in skeletal muscle arterioles
por: Stone, Audrey J., et al.
Publicado: (2014)

Mitochondrial energetics is impaired in vivo in aged skeletal muscle
por: Gouspillou, Gilles, et al.
Publicado: (2014)

Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats
por: Liu, Yang, et al.
Publicado: (2021)

Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study
por: Mettu, Priyatham S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r2kt4305eh20n1fd9l0p1rh161